Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter? - Andrews - 20....

Abstract Background Optimal sequencing of systemic therapy in the management for metastatic castration resistant prostate cancer (mCRPC) remains poorly elucidated. The CHAARTED and STAMPEDE studies...

Prostate Cancer: Types of Treatment | Cancer.Net

Prostate Cancer: Types of Treatment Approved by the Cancer.Net Editorial Board, 12/2022 ON THIS PAGE: You will learn about the different types of treatments doctors use for people with...

NAVER 학술정보 > Circulating tumor cells predict survival benefit from treatment in metastatic castration....

저자 : Johann S de Bono, Howard I Scher, R Bruce Montgomery, Christopher Parker, M Craig Miller, Henk Tissing, Gerald V Doyle, Leon W W M Terstappen, Kenneth J Pienta, Derek Raghavan, 학술지정보 : CLINICAL CANCER RESEARCH · 6302p ~ 6311p · ISSN 1078-0432 · E-ISSN 1557-3265, 발행정보 : Medline · 2008년, 피인용횟수 : 2,054, 자료제공처 : MEDLINE®/PubMed® · Crossref, DOI : 10.1158/1078-0432.CCR-08-0872, 주제분야 : 의약학 > 방사선종양학 , 의약학 > 내과학 , 의약학 > 약학, 키워드 ...

Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer A Systematic Review....

Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer A Systematic Review and Network Meta-analysis

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prosta....

in castration-resistant prostate cancer (CRPC). Secondary... before treatment and monthly thereafter. Patients were... with metastatic breast, prostate, and colorectal cancers (8–15)...

Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to d....

facing metastatic castration-resistant prostate cancer (CRPC). More recently, efforts have been directed at trying to effect change at earlier phases of the disease. Apalutamide (ARN-509)...

Effectiveness and tolerability of targeted drugs for the treatment of metastatic - Merck

Effectiveness and tolerability of targeted drugs for the treatment of metastatic castration-resistant prostate cancer: a network meta-analysis of randomized controlled trials. by Yongquan Wang, Hen...

Prognostic factors of oncologic outcomes in metastatic chemotherapy-naïve castration-resistant prostate ....

Kim, Choung-Soo 발행기관 Elsevier 학술지명 Urologic oncology 권호사항 Vol.36 No.9 [2018] 발행연도 2018 작성언어 - 주제어 Castration-resistant prostate cancer ; Enzalutamide...

Visceral disease in castration-resistant prostate cancer

Metastatic involvement of the viscera in men with advanced castration-resistant prostate cancer (CRPC) has been poorly characterised to date. In 359 CRPC patients treated between June 2003 and Dece...

[논문]Impact of cabazitaxel on 2-year survival and palliation of tumour-related pa - 과학기술 지식인프라 ....

BackgroundCabazitaxel significantly improves overall survival (OS) versus mitoxantrone in patients with metastatic castration-resistant prostate cancer after docetaxel failure. We examined patient...